These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38549761)

  • 21. Radiomic features predict Ki-67 expression level and survival in lower grade gliomas.
    Li Y; Qian Z; Xu K; Wang K; Fan X; Li S; Liu X; Wang Y; Jiang T
    J Neurooncol; 2017 Nov; 135(2):317-324. PubMed ID: 28900812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of combined intraoperative electrophysiological investigation with 3-T intraoperative MRI for awake cerebral glioma surgery: comprehensive review of the clinical implications and radiological outcomes.
    Ghinda D; Zhang N; Lu J; Yao CJ; Yuan S; Wu JS
    Neurosurg Focus; 2016 Mar; 40(3):E14. PubMed ID: 26926054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosing growth in low-grade gliomas with and without longitudinal volume measurements: A retrospective observational study.
    Fathallah-Shaykh HM; DeAtkine A; Coffee E; Khayat E; Bag AK; Han X; Warren PP; Bredel M; Fiveash J; Markert J; Bouaynaya N; Nabors LB
    PLoS Med; 2019 May; 16(5):e1002810. PubMed ID: 31136584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normal-appearing white matter structural integrity in incidentally discovered low-grade gliomas: a single institution study.
    Cargnelutti E; Maieron M; Ius T; Skrap M; Tomasino B
    J Neurosurg Sci; 2023 Apr; 67(2):200-205. PubMed ID: 33245224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavior-Oriented Nomogram for the Stratification of Lower-Grade Gliomas to Improve Individualized Treatment.
    Wei RL; Zhang LW; Li JG; Yang FD; Xue YK; Wei XT
    Front Oncol; 2020; 10():538133. PubMed ID: 33392065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status.
    Grabner G; Kiesel B; Wöhrer A; Millesi M; Wurzer A; Göd S; Mallouhi A; Knosp E; Marosi C; Trattnig S; Wolfsberger S; Preusser M; Widhalm G
    Eur Radiol; 2017 Apr; 27(4):1556-1567. PubMed ID: 27300198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
    Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
    J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups.
    Juratli TA; Tummala SS; Riedl A; Daubner D; Hennig S; Penson T; Zolal A; Thiede C; Schackert G; Krex D; Miller JJ; Cahill DP
    J Neurooncol; 2019 Jan; 141(2):327-335. PubMed ID: 30536195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
    Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
    Front Immunol; 2022; 13():933973. PubMed ID: 36045691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.
    Hsu DW; Louis DN; Efird JT; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1997 Aug; 56(8):857-65. PubMed ID: 9258255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas.
    Ye L; Xu Y; Hu P; Wang L; Yang J; Yuan F; Wang Y; Zhang C; Tian D; Chen Q
    Front Mol Neurosci; 2021; 14():720899. PubMed ID: 34776862
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuropathological and neuroradiological spectrum of pediatric malignant gliomas: correlation with outcome.
    Puget S; Boddaert N; Veillard AS; Garnett M; Miquel C; Andreiuolo F; Sainte-Rose C; Roujeau T; DiRocco F; Bourgeois M; Zerah M; Doz F; Grill J; Varlet P
    Neurosurgery; 2011 Jul; 69(1):215-24. PubMed ID: 21368704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of Corticosteroids and Antiepileptic Drugs on Visible 5-Aminolevulinic Acid Fluorescence in a Series of Initially Suspected Low-Grade Gliomas Including World Health Organization Grade II, III, and IV Gliomas.
    Wadiura LI; Mischkulnig M; Hosmann A; Borkovec M; Kiesel B; Rötzer T; Mercea PA; Furtner J; Hervey-Jumper S; Rössler K; Berger MS; Widhalm G
    World Neurosurg; 2020 May; 137():e437-e446. PubMed ID: 32045726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA copy number analysis of Grade II-III and Grade IV gliomas reveals differences in molecular ontogeny including chromothripsis associated with IDH mutation status.
    Cohen A; Sato M; Aldape K; Mason CC; Alfaro-Munoz K; Heathcock L; South ST; Abegglen LM; Schiffman JD; Colman H
    Acta Neuropathol Commun; 2015 Jun; 3():34. PubMed ID: 26091668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing intracranial incidental findings suggestive of low-grade glioma: learning from experience.
    Shah AH; Madhavan K; Sastry A; Komotar RJ
    World Neurosurg; 2013 Nov; 80(5):e75-7. PubMed ID: 22722044
    [No Abstract]   [Full Text] [Related]  

  • 38. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
    Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The imaging features and prognosis of gliomas involving the subventricular zone: An MRI study.
    Zhao K; Liu R; Li Z; Liu M; Zhao Y; Xue Z; Wu W; Sun G; Xu B
    Clin Neurol Neurosurg; 2022 Nov; 222():107465. PubMed ID: 36201899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of intraoperative ultrasound characteristics with pathological grades and Ki-67 proliferation index in intracranial gliomas.
    Baskan O; Silav G; Sari R; Canoz O; Elmaci I
    J Med Ultrason (2001); 2015 Apr; 42(2):231-7. PubMed ID: 26576577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.